ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Yanagida, Satoshi ^a,b   Taniue, Kenzui ^a   Sugimasa, Hironobu ^a   Nasu, Emiko ^a   Takeda, Yasuko ^a   Kobayashi, Mana ^a   Yamamoto, Tadashi ^a   Okamoto, Aikou ^b   Akiyama, Tetsu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BTG3 PROTEIN, HUMAN; COMPLEMENTARY RNA; PROTEIN; UNTRANSLATED RNA;

APOPTOSIS; ARTICLE; CARCINOMA; CELL NUCLEUS; CELL TRANSFORMATION; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENE ORDER; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

APOPTOSIS; BIOLOGICAL TRANSPORT; CARCINOMA; CELL LINE, TUMOR; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE ORDER; HUMANS; OVARIAN NEOPLASMS; PROTEINS; RNA, ANTISENSE; RNA, UNTRANSLATED; TRANSCRIPTION, GENETIC;

MLCS; MLOWN;

EID: 84874314357     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01305     Document Type: Article

References (24)

1. Katayama, S. et al. Antisense transcription in the mamalian transcriptome. Science 309, 1564-1566 (2005).
2. Faghihi, M. A. & Wahlestedt, C. Regulatory roles of natural antisense transcripts. Nat. Rev. Mol. Cell Biol. 10, 637-643 (2009).
3. Hastings, M. L., Milcarek, C., Martincic, K., Peterson, M. L. & Munroe, S. H. Expression of the thyroid hormone receptor gene, erbAalpha, in B lymphocytes: alternative mRNA processing is independent of differentiation but correlates with antisense RNA levels. Nucleic Acids Res. 25, 4296-4300 (1997).
4. Peters, N. T., Rohrbach, J. A., Zalewski, B. A., Byrkett, C. M. & Vaughn, J. C. RNA editing and regulation of Drosophila 4f-rnp expression by sas-10 antisense readthrough mRNA transcripts. RNA 9, 698-710 (2003).
5. Faghihi, M. A. et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 14, 723-730 (2008).
6. Matsui, K. et al. Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes. Hepatology 47, 686-697 (2008).
7. Uchida, T. et al. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J. Biol. Chem. 279, 14871-14878 (2004).
8. Hatzoglou, A. et al. Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue. BMC Mol. Biol. 3, 4 (2002).
9. Ebralidze, A. K. et al. PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes Dev. 22, 2085-2092 (2008).
10. Mahmoudi, S. et al. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol. Cell 33, 462-471 (2009).
11. Tufarelli, C. et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat. Genet. 34, 157-165 (2003).
12. Yu, W. et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451, 202-206 (2008).
13. Morris, K. V., Santoso, S., Turner, A. M., Pastori, C. & Hawkins, P. G. Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet. 4, e1000258 (2008).
14. Winkler, G. S. The mammalian anti-proliferative BTG/Tob protein family. J. Cell. Phys. 222, 66-72 (2010).
15. Lin, T. Y. et al. Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16(INK4a) signaling axis. Oncogene 31, 3287-3297 (2012).
16. Ou, Y. H. et al. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J. 26, 3968-3980 (2007).
17. Yoshida, Y., Hosoda, E., Nakamura, T. & Yamamoto, T. Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex. Jan. J. Cancer Res. 92, 592-596 (2001).
18. Majid, S. et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 30, 662-670 (2009).
19. Yoneda, M. et al. Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma. Cancer Sci. 100, 225-232 (2009).
20. Mahmoudi, S. et al. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol. Cell 33, 462-471 (2009).
21. Dallosso, A. R. et al. Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer. RNA 13, 2287-2299 (2007).
22. Tripathi, V. et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39, 925-938 (2010).
23. Lim, F. & Peabody, D. S. RNA recognition site of PP7 coat protein. Nucleic Acids Res. 30, 4138-4144 (2002).
24. Lim, F., Downey, T. P. & Peabody, D.S. Translational repressionand specific RNA binding by the coat protein of the Pseudomonas phage PP7. J. Biol. Chem. 276, 22507-22513 (2001).